Login
value-dx
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Press
    • Events
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform
  • Search
  • Menu
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Press
    • Events
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform

Archive for month: November, 2020

You are here: Home / 2020 / November
News

ESCMID Policy Statement: addressing the lack of availability of existing antibiotics

November 26, 2020
https://value-dx.eu/wp-content/uploads/2019/08/ESCMID-Web.png 300 300 Daniele Pazzola https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Daniele Pazzola2020-11-26 11:49:102020-11-26 11:52:35ESCMID Policy Statement: addressing the lack of availability of existing antibiotics
News

VALUE-Dx at Virtual ISPOR Europe 2020

November 17, 2020
https://value-dx.eu/wp-content/uploads/2020/11/ispo.png 720 1280 Tina Hofland https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Tina Hofland2020-11-17 14:29:442020-11-18 08:33:48VALUE-Dx at Virtual ISPOR Europe 2020

Social Media

Twitter
LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 820755. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and bioMérieux SA, Janssen Pharmaceutica NV, Accelerate Diagnostics S.L., Abbott, Bio-Rad Laboratories, BD Switzerland Sàrl, and The Wellcome Trust Limited.

Copyright - Value-Dx - The communication reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
Scroll to top
We use cookies to ensure that we can give you the best experience on our website. AcceptRefuseRead More